Olelko Vladimirovich

Recent publications · Crossref

5 total works indexed

1. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

   · 2021 · cited 576x

2. Methods in the Quantum Theory of Magnetism

   · 1967 · cited 553x

3. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes

   · 2018 · cited 416x

4. Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.

   · 2022 · cited 349x

5. IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC).

   · 2021 · cited 273x

via Crossref · CC0

Wikidata facts